Eisai
Eisai collaborates on psychiatric disorder research
July 16, 2010Research and Development Aestus Thereapeutics, Eisai
Eisai is to work with US-based translational medicine company Aestus Therapeutics to develop novel treatments for psychiatric disorders. The companies’ …
Eisai’s breast cancer drug impresses at ASCO
June 9, 2010Research and Development ASCO, Eisai, Xeloda, eribulin
A new cancer drug developed by Japanese pharma company Eisai has shown promise in increasing overall survival rates in heavily …
Eisai opens $100m parenterals plant in North Carolina
May 24, 2010Manufacturing and Production, Research and Development Aricept, Eisai, eribulin, parenterals
Japanese drugmaker Eisai has opened a 65,000-sq.ft. facility at Research Triangle Park in North Carolina, USA, which will serve as …
Eisai looks to India for API production
January 8, 2010Manufacturing and Production, Research and Development Eisai, India
Japanese drugmaker Eisai has started operations at a manufacturing and research facility in Visakhapatnam, southern India, which will be the …
Eisai opens new European HQ in the UK
July 8, 2009Manufacturing and Production, Research and Development, Sales and Marketing Eisai, Europe, HQ
Eisai has officially opened its new European headquarters in the UK, its biggest-ever single capital investment that will bring teams …
Eisai signs $3.9bn biotech deal
December 14, 2007Research and Development, Sales and Marketing Eisai
Japanese pharma company Eisai has acquired Minnesota-based biotech MGI Pharma for $3.9 billion, significantly boosting its oncology business.It is Eisai’s …
Eisai gets go ahead for Alzheimer’s appeal
December 10, 2007Alzheimer's, Eisai, NICE
Eisai is to make one more legal challenge to NICE by taking its case on Alzheimer’s drugs to the Court …
Eisai to appeal against Alzheimer’s court ruling
October 3, 2007Alzheimer's, Eisai, NICE
Eisai and Pfizer are to try once again to reverse NICE restrictions on Alzheimer’s drugs by appealing against the recent …
Eisai to buy biotech Morphotek
March 23, 2007Sales and Marketing Eisai, biotech
Eisai is to acquire Morphotek for $325 million, making it the latest pharma company to buy outright a biotech company …
Latest content
Five Facts about cardiovascular disease
